Expression of DNA mismatch repair proteins in transformed non-Hodgkin's lymphoma: Relationship to smoking

References

• Howe H L, Wingo P A, Thun M J, Ries L A, Rosenberg H M, Feigal E G, et al. Annual Report to the Nation on the Status of Cancer (1973 Through 1998), Featuring Cancers With Recent Increasing Trends. J Natl Cancer Inst 2001; 93: 824–842
   PubMed Web of Science ®Google Scholar
• Clarke C A, Glaser S L. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002; 94: 2015–2023
   PubMed Web of Science ®Google Scholar
• Bray I, Brennan P, Boffetta P. Recent trends and future projections of lymphoid neoplasms – a Bayesian age – period – cohort analysis. Cancer Causes Control 2001; 12: 813–820
   PubMed Web of Science ®Google Scholar
• SEER Cancer Statistics Review, 1973 – 1998, L AG Ries, M P Eisner, C L Kosary, B F Hankey, B A Miller, L Clegg, B K Edwards. National Cancer Institute, Bethesda, MD, Available at http://seer.cancer.gov/publications/CSR1973_1998/2001
   Google Scholar
• Pearce N, Bethwaite P. Increasing incidence of non-Hodgkin's lymphoma: occupational and environmental factors. Cancer Res 1992; 52: 5496s–5500s
   PubMed Web of Science ®Google Scholar
• Lo Coco F, Gaidano G, Louie D C, Offit K, Chaganti R S, Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289–2295
   PubMed Web of Science ®Google Scholar
• Giles F J, O'Brien S M, Keating M J. Chronic lymphocytic leukemia in (Richter's) transformation. Semin Oncol 1998; 25: 117–125
   PubMed Web of Science ®Google Scholar
• Sander C A, Yano T, Clark H M, Harris C, Longo D L, Jaffe E S, et al. p53 mutation is associated with progression in follicular lymphomas. Blood 1993; 7: 1994–2004
   Google Scholar
• Dalla-Fevera R, Ye B H, Lo Coco F. Identification of genetic lesions associated with diffuse large-cell lymphoma. Ann Oncol 1994; 5: S55–S60
   PubMed Web of Science ®Google Scholar
• Auilar-Santelises M, Magnusson K P, Wiman K G, Mellstedt H, Jondal M. Progressive B-cell chronic lymphocytic leukemia frequently exhibits aberrant p53 expression. Int J Cancer 1994; 58: 474–479
   PubMed Web of Science ®Google Scholar
• Bea S, Lopez-Gillermo A, Ribas M, Puig X, Pinyol M, Carrio A, et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome). Am J Pathol 2002; 161: 957–968
   PubMed Web of Science ®Google Scholar
• Nagy M, Balazs M, Adam Z, Petko Z, Timar B, Szereday Z, et al. Genetic instability is associated with histological transformation of follicle center lymphoma. Leukemia 2000; 14: 2142–2148
   PubMed Web of Science ®Google Scholar
• Gartenhaus R, Johns M M, 3rd, Wang P, Rai K, Sidransky D. Mutator phenotype in a subset of chronic lymphocytic leukemia. Blood 1996; 87: 38–41
   PubMed Web of Science ®Google Scholar
• Sanz-Vaque L, Colomer D, Bosch F, Lopez-Guillermo A, Dreyling M H, Ott G, et al. Microsatellite instability analysis in typical and progressed mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Haematologica 2001; 86: 181–186
   PubMed Web of Science ®Google Scholar
• Volpe G, Gamberi B, Pastore C, Roetto A, Pautasso M, Parvis G, et al. Analysis of microsatellite instability in chronic lymphoproliferative disorders. Ann Hematol 1996; 72: 67–71
   PubMed Web of Science ®Google Scholar
• U.S. EPA. Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. U.S. Environmental Protection Agency, Washington, DC 1992, EPA/600/6-90/006F
   Google Scholar
• Brown L M, Everett G D, Gibson R, Burmeister L F, Schuman L M, Blair A. Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma. Cancer Causes Control 1992; 3: 49–55
   PubMed Web of Science ®Google Scholar
• Herrinton L J, Friedman G D. Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes. Cancer Epidemiol Biomarkers Prev 1998; 7: 25–28
   PubMed Web of Science ®Google Scholar
• Parker A S, Cerhan J R, Dick F, Kemp J, Habermann T M, Wallace R B, et al. Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women. Leuk Lymphoma 2000; 37: 341–349
   PubMed Web of Science ®Google Scholar
• Stagnaro E, Ramazzotti V, Crosignani P, Fontana A, Masala G, Miligi L, et al. Smoking and hematolymphopoietic malignancies. Cancer Causes Control 2001; 12: 325–334
   PubMed Web of Science ®Google Scholar
• Bell D, Liu Y, Cortopassi G. Occurrence of bcl-2 oncogene translocation with increased frequency in peripheral blood of heavy smokers. J Natl Cancer Inst 1995; 87: 223–224
   PubMed Web of Science ®Google Scholar
• Miligi L, Seniori Costantini A, Crosignani P, Fontana A, Masala G, Nanni O, et al. Occupational, environmental and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med 1999; 36: 60–69
   PubMed Web of Science ®Google Scholar
• Brown L M, Gibson R, Blair A, Burmeister L F, Schumann L M, Cantor K P, et al. Smoking and risk of leukemia. Am J Epidemiol 1992; 135: 763–768
   PubMed Web of Science ®Google Scholar
• Gealy R, Zhang L, Siegfried J M, Luketich J D, Keohavong P. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Cancer Epidemiol Biomarkers Prev 1999; 8: 297–302
   PubMed Web of Science ®Google Scholar
• Slattery M L, Curtin K, Anderson K, Ma K -N, Ballard L, Edwards S, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000; 92: 1831–1836
   PubMed Web of Science ®Google Scholar
• Erber R, Conradt C, Homann N, Enders C, Finckh M, Dietz A, et al. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene 1998; 16: 1671–1679
   PubMed Web of Science ®Google Scholar
• Baas I O, Mulder J W, Offerhaus G J, Vogelstein B, Hamilton S R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172: 5–12
   PubMed Web of Science ®Google Scholar
• Kressner U, Inganas M, Byding S, Blikstad I, Pahlman L, Glimelius B, et al. Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol 1999; 17: 593–599
   PubMed Web of Science ®Google Scholar
• Renkonen E, Zhang Y, Lohi H, Salovaara R, Abdel-Rahman W M, Nilbert F, et al. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol 2003; 19: 3629–3637
   Web of Science ®Google Scholar
• Zahm S H, Weisenburger D D, Holmes F F, Cantor K P, Blair A. Tobacco and non-Hodgkin's lymphoma: combined analysis of three case-control studies (United States). Cancer Causes Control 1997; 8: 159–166
   PubMed Web of Science ®Google Scholar
• Morton L M, Holford T R, Leaderer B, Boyle P, Zahm S H, Zhang Y, et al. Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women. Br J Cancer 2003; 89: 2087–2092
   PubMed Web of Science ®Google Scholar
• Umar A, Kunkel T A. DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur J Biochem 1996; 238: 297–307
   PubMedGoogle Scholar
• Gartenhaus R B. Microsatellite instability in hematologic malignancies. Leuk Lymphoma 1997; 25: 455–461
   PubMed Web of Science ®Google Scholar
• Fulop Z, Csernus B, Timar B, Szepesi A, Matolcsy A. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Leukemia 2003; 17(2)411–415
   PubMed Web of Science ®Google Scholar
• Shen L, Kondo Y, Hamilton S R, Rashid A, Issa J P. p14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology 2003; 124: 626–633
   Google Scholar
• Thornton P D, Gruszka-Westwood A M, Hamoudi R A, Atkinson S, Kaczmarek P, Morilla R M, et al. Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia. Hematol J 2004; 5(1)47–54
   PubMedGoogle Scholar
• Kupper M, Joos S, von Bonin F, Daus H, Pfreundschuh M, Lichter P, et al. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies. Br J Haematol 2001; 112(3)768–775
   PubMed Web of Science ®Google Scholar
• Petit B, Leroy K, Kanavaros P, Boulland M L, Druet-Cabanac M, Haioun C, et al. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations. Hum Pathol 2001; 32(2)196–204
   PubMed Web of Science ®Google Scholar